AnalystsBiren AminBiren Amin's Stock Forecasts
AnalystsBiren Amin
Sectors:
Analyst Ranking
Bottom 6%
#4311 out of 4577 analysts
Average Return
-10.43%
Win Rate
41%9 out of 22
Risk vs Reward
Poor
Good
Biren Amin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | +92.27% | $61.94 | $119.09 | 2017-10-02 - 2018-10-03 | Strong Buy |
Zentalis Pharmaceuticals IncZNTL | +67.39% | $35.57 | $59.54 | 2020-04-27 - 2021-04-28 | Strong Buy |
Aldeyra Therapeutics IncALDX | +36.23% | $6.68 | $9.10 | 2020-10-29 - 2021-10-29 | Strong Buy |
Minerva Neurosciences IncNERV | +34.65% | $44.56 | $60.00 | 2016-05-11 - 2017-05-12 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +32.41% | $132.17 | $175.01 | 2017-07-10 - 2018-07-11 | Strong Buy |
Biren Amin Analyst Color
Get additional color on Biren Amin's coverage of popular stocks
Biren Amin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $70.00 | +468.64% | Maintains | a year ago |
Quince Therapeutics IncQNCX | 2 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 3 years ago |
Urovant Sciences LtdUROV | 1 | Hold | $16.25 | N/A | Downgrades | 3 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 4 years ago |
Kala Bio IncKALA | 2 | Hold | $500.00 | N/A | Downgrades | 4 years ago |
Immatics NvIMTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $492.00 | N/A | Upgrades | 4 years ago |
Synthorx IncTHOR | 1 | Hold | $68.00 | N/A | Downgrades | 4 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Hold | $2,400.00 | N/A | Downgrades | 6 years ago |
Armo Biosciences IncARMO | 1 | Hold | $50.00 | N/A | Downgrades | 6 years ago |
Bluebird Bio IncBLUE | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $101.00 | N/A | Initiates Coverage On | 6 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $69.00 | N/A | Maintains | 7 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $155.00 | N/A | Initiates Coverage On | 7 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Minerva Neurosciences IncNERV | 4 | Strong Buy | $136.00 | N/A | Initiates Coverage On | 7 years ago |
Obseva SaOBSVF | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.